Last reviewed · How we verify
NCT03849092
Smoking Cessation: Financial Incentives
NA trial testing Financial incentives in Smoking Cessation in 1,934 participants. Completed in 30 July 2020.
31 December 2019
Quick facts
| Lead sponsor | Glostrup University Hospital, Copenhagen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,934 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2019 |
| Estimated completion | 30 July 2020 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Financial incentives
- Campaigns
Conditions studied
- Smoking Cessation — all drugs for Smoking Cessation →
Sponsor
Glostrup University Hospital, Copenhagen
Who can join
Eligibility, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this intervention is to test if the investigator, by offering a financial incentive to smokers who abstinence from smoking, can: 1. recruit more smokers with low socioeconomic status to municipal smoking cessation programs 2. achieve higher abstinence rates at municipal smoking cessation programs among citizens with low economic status - Rather than by use of campaigns (=usual strategy) informing citizens about their options for support at municipal smoking cessation programs?
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Smoking Cessation Programs Are Less Effective in Smokers with Low Socioeconomic Status Even When Financial Incentives for Quitting Smoking Are Offered-A Community-Randomized Smoking Cessation Trial in Denmark.
Pisinger C, Toxværd CG, Rasmussen M. · · 2022 · cited 6× · PMID 36078595 · DOI 10.3390/ijerph191710879 -
Are financial incentives more effective than health campaigns to quit smoking? A community-randomised smoking cessation trial in Denmark.
Pisinger C, Toxværd CG, Rasmussen M. · · 2022 · cited 4× · PMID 34740676 · DOI 10.1016/j.ypmed.2021.106865
Verify or expand the search:
- PubMed search for NCT03849092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Financial incentives
Trials testing the same drug.
- NCT06288711 — Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD · NA · recruiting
- NCT05322044 — Financial Incentives to Improve Asthma · NA · completed
- NCT04902326 — Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change) · NA · completed
- NCT04917926 — Behavioural Economics-based Incentives in Adults With Type 2 Diabetes (BET2) · NA · completed
- NCT04445662 — Financial Incentives for Homeless Smokers: A Community-based RCT · NA · completed
Other recruiting trials for Smoking Cessation
Currently open trials in the same condition.
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
- NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
- NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
Other Glostrup University Hospital, Copenhagen trials
Trials by the same sponsor.
- NCT07442773 — Intervention to Support Partners and Informal Caregivers of Frail RA-patients · NA · recruiting
- NCT07318129 — Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis · NA · recruiting
- NCT07105514 — Indole-3-PROpionic Acid Clinical Trials - a Pilot Study Part 2 · NA · recruiting
- NCT06533423 — Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial · NA · recruiting
- NCT06674018 — Indole-3-PROpionic Acid Clinical Trials - a Pilot Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03849092 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Glostrup University Hospital, Copenhagen
- Last refreshed: 26 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03849092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing